The University of Texas Health Science Center at Houston Medical School has just launched a unique clinical trial which studies two forms of stem cells treatments for children with cerebral palsy. Led by Charles S. Cox, Jr., M.D. of the Children’s Fund, Inc., the study will compare the safety and effectiveness of banked cord blood to bone marrow stem cells. Dr. Cox is a Distinguished Professor of Pediatric Surgery at the UTHealth Medical School and director of the Pediatric Trauma Program at Children’s Memorial Hermann Hospital.
The study, which is the first of its kind to be conducted, is based on Dr. Cox’s research of stem cell therapy for both children and adults, specifically after suffering from a traumatic brain injury (TBI). He is also assessing the impact of cord blood stem cell treatment for TBI in another trial.
30 children with CP will participate in the trial, which is double-blinded and will include a placebo control group. The children will be monitored after receiving the treatments, and will have follow-up visits at six, 12 and 24 months.
CBR, Let’s Cure CP, TIRR Foundation and Children’s Memorial Hermann Hospital are all collaborating for the study.